Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 34.72
+0.23 (0.67%)
Last updated: Jul 17, 2025
SHE:301089 Revenue
Tuoxin Pharmaceutical Group had revenue of 96.99M CNY in the quarter ending March 31, 2025, a decrease of -10.46%. This brings the company's revenue in the last twelve months to 410.37M, up 4.47% year-over-year. In the year 2024, Tuoxin Pharmaceutical Group had annual revenue of 421.69M, down -49.53%.
Revenue (ttm)
410.37M
Revenue Growth
+4.47%
P/S Ratio
10.71
Revenue / Employee
264.58K
Employees
1,551
Market Cap
4.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 421.69M | -413.82M | -49.53% |
| Dec 31, 2023 | 835.51M | 50.79M | 6.47% |
| Jan 1, 2023 | 784.72M | 282.24M | 56.17% |
| Jan 1, 2022 | 502.48M | -25.46M | -4.82% |
| Dec 31, 2020 | 527.94M | 141.98M | 36.79% |
| Jan 1, 2020 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |